FULC Annual SG&A
$41.67 M
-$26.00 K-0.06%
31 December 2023
Summary:
As of January 19, 2025, FULC annual selling, general & administrative expenses is $41.67 million, with the most recent change of -$26.00 thousand (-0.06%) on December 31, 2023. During the last 3 years, it has risen by +$20.28 million (+94.78%). FULC annual SG&A is now -0.06% below its all-time high of $41.69 million, reached on December 31, 2022.FULC Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FULC Quarterly SG&A
$8.42 M
-$1.82 M-17.79%
30 September 2024
Summary:
As of January 19, 2025, FULC quarterly selling, general & administrative expenses is $8.42 million, with the most recent change of -$1.82 million (-17.79%) on September 30, 2024. Over the past year, it has dropped by -$1.44 million (-14.60%). FULC quarterly SG&A is now -26.88% below its all-time high of $11.52 million, reached on March 31, 2023.FULC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FULC TTM SG&A
-$2.03 B
-$17.91 M-0.89%
30 September 2024
Summary:
As of January 19, 2025, FULC TTM selling, general & administrative expenses is -$2.03 billion, with the most recent change of -$17.91 million (-0.89%) on September 30, 2024. Over the past year, it has dropped by -$2.07 billion (-4972.28%). FULC TTM SG&A is now -2880.12% below its all-time high of $42.45 million, reached on March 31, 2023.FULC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FULC Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.1% | -14.6% | -4972.3% |
| 3 y3 years | +94.8% | -14.6% | -4972.3% |
| 5 y5 years | +401.2% | -14.6% | -4972.3% |
FULC Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.1% | +36.5% | -26.9% | at low | -88.3% | at low |
| 5 y | 5-year | -0.1% | +217.0% | -26.9% | +91.3% | -299.2% | at low |
| alltime | all time | -0.1% | +826.2% | -26.9% | +385.0% | -2880.1% | at low |
Fulcrum Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.42 M(-17.8%) | $38.60 M(-3.8%) |
| June 2024 | - | $10.25 M(+1.8%) | $40.13 M(-0.2%) |
| Mar 2024 | - | $10.06 M(+2.0%) | $40.21 M(-3.5%) |
| Dec 2023 | $41.67 M(-0.1%) | $9.86 M(-1.0%) | $41.67 M(-0.6%) |
| Sept 2023 | - | $9.96 M(-3.5%) | $41.93 M(+0.6%) |
| June 2023 | - | $10.32 M(-10.4%) | $41.68 M(-1.8%) |
| Mar 2023 | - | $11.52 M(+13.7%) | $42.45 M(+1.8%) |
| Dec 2022 | $41.69 M(+36.6%) | $10.13 M(+4.4%) | $41.69 M(+1.0%) |
| Sept 2022 | - | $9.71 M(-12.5%) | $41.27 M(+2.7%) |
| June 2022 | - | $11.10 M(+3.2%) | $40.19 M(+12.3%) |
| Mar 2022 | - | $10.76 M(+10.9%) | $35.78 M(+17.2%) |
| Dec 2021 | $30.52 M | $9.71 M(+12.5%) | $30.52 M(+14.4%) |
| Sept 2021 | - | $8.63 M(+29.1%) | $26.68 M(+14.2%) |
| June 2021 | - | $6.68 M(+21.6%) | $23.36 M(+7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $5.50 M(-6.3%) | $21.83 M(+2.0%) |
| Dec 2020 | $21.39 M(+62.7%) | $5.87 M(+10.4%) | $21.39 M(+7.3%) |
| Sept 2020 | - | $5.31 M(+3.2%) | $19.93 M(+9.9%) |
| June 2020 | - | $5.15 M(+1.7%) | $18.13 M(+16.1%) |
| Mar 2020 | - | $5.06 M(+15.0%) | $15.61 M(+18.8%) |
| Dec 2019 | $13.14 M(+58.1%) | $4.40 M(+25.4%) | $13.14 M(+18.1%) |
| Sept 2019 | - | $3.51 M(+33.3%) | $11.13 M(+14.2%) |
| June 2019 | - | $2.63 M(+1.4%) | $9.75 M(+6.2%) |
| Mar 2019 | - | $2.60 M(+8.7%) | $9.18 M(+10.4%) |
| Dec 2018 | $8.31 M(+84.8%) | $2.39 M(+12.5%) | $8.31 M(+40.4%) |
| Sept 2018 | - | $2.13 M(+3.1%) | $5.92 M(+56.0%) |
| June 2018 | - | $2.06 M(+18.7%) | $3.80 M(+118.7%) |
| Mar 2018 | - | $1.74 M | $1.74 M |
| Dec 2017 | $4.50 M | - | - |
FAQ
- What is Fulcrum Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual SG&A year-on-year change?
- What is Fulcrum Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly SG&A year-on-year change?
- What is Fulcrum Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics TTM SG&A year-on-year change?
What is Fulcrum Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of FULC is $41.67 M
What is the all time high annual SG&A for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual selling, general & administrative expenses is $41.69 M
What is Fulcrum Therapeutics annual SG&A year-on-year change?
Over the past year, FULC annual selling, general & administrative expenses has changed by -$26.00 K (-0.06%)
What is Fulcrum Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of FULC is $8.42 M
What is the all time high quarterly SG&A for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly selling, general & administrative expenses is $11.52 M
What is Fulcrum Therapeutics quarterly SG&A year-on-year change?
Over the past year, FULC quarterly selling, general & administrative expenses has changed by -$1.44 M (-14.60%)
What is Fulcrum Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of FULC is -$2.03 B
What is the all time high TTM SG&A for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high TTM selling, general & administrative expenses is $42.45 M
What is Fulcrum Therapeutics TTM SG&A year-on-year change?
Over the past year, FULC TTM selling, general & administrative expenses has changed by -$2.07 B (-4972.28%)